메뉴 건너뛰기




Volumn 150, Issue 5, 2010, Pages 666-673

Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; INDOCYANINE GREEN; MONOCLONAL ANTIBODY;

EID: 78049452086     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.05.035     Document Type: Article
Times cited : (97)

References (20)
  • 1
    • 33749451356 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • D.M. Brown, P.K. Kaiser, and M. Michels Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
    • (2006) N Engl J Med , vol.355 , Issue.14 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 2
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • P.J. Rosenfeld, D.M. Brown, and J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
    • (2006) N Engl J Med , vol.355 , Issue.14 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 3
    • 57949094834 scopus 로고    scopus 로고
    • Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
    • D.M. Brown, M. Michels, and P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65
    • (2009) Ophthalmology , vol.116 , Issue.1 , pp. 57-65
    • Brown, D.M.1    Michels, M.2    Kaiser, P.K.3
  • 4
    • 67149101784 scopus 로고    scopus 로고
    • A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: Year 2 of the PrONTO Study
    • G.A. Lalwani, P.J. Rosenfeld, and A.E. Fung A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study Am J Ophthalmol 148 1 2009 43 58
    • (2009) Am J Ophthalmol , vol.148 , Issue.1 , pp. 43-58
    • Lalwani, G.A.1    Rosenfeld, P.J.2    Fung, A.E.3
  • 5
    • 0028897863 scopus 로고
    • Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy
    • R.F. Spaide, L.A. Yannuzzi, and J.S. Slakter Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy Retina 15 2 1995 100 110
    • (1995) Retina , vol.15 , Issue.2 , pp. 100-110
    • Spaide, R.F.1    Yannuzzi, L.A.2    Slakter, J.S.3
  • 6
    • 63249130897 scopus 로고    scopus 로고
    • A classification system for polypoidal choroidal vasculopathy
    • P. Cackett, D. Wong, and I. Yeo A classification system for polypoidal choroidal vasculopathy Retina 29 2 2009 187 191
    • (2009) Retina , vol.29 , Issue.2 , pp. 187-191
    • Cackett, P.1    Wong, D.2    Yeo, I.3
  • 7
    • 52949129894 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: A report by the American Academy of Ophthalmology
    • M.S. Ip, I.U. Scott, and G.C. Brown Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology Ophthalmology 115 10 2008 1837 1846
    • (2008) Ophthalmology , vol.115 , Issue.10 , pp. 1837-1846
    • Ip, M.S.1    Scott, I.U.2    Brown, G.C.3
  • 8
    • 34547454184 scopus 로고    scopus 로고
    • Guidance for the treatment of neovascular age-related macular degeneration
    • U.M. Schmidt-Erfurth, G. Richard, and A. Augustin Guidance for the treatment of neovascular age-related macular degeneration Acta Ophthalmol Scand 85 5 2007 486 494
    • (2007) Acta Ophthalmol Scand , vol.85 , Issue.5 , pp. 486-494
    • Schmidt-Erfurth, U.M.1    Richard, G.2    Augustin, A.3
  • 9
    • 33947403618 scopus 로고    scopus 로고
    • An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration
    • A.E. Fung, G.A. Lalwani, and P.J. Rosenfeld An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 4 2007 566 583
    • (2007) Am J Ophthalmol , vol.143 , Issue.4 , pp. 566-583
    • Fung, A.E.1    Lalwani, G.A.2    Rosenfeld, P.J.3
  • 10
    • 36249004373 scopus 로고    scopus 로고
    • The synergistic action of a VEGF-receptor tyrosine-kinase inhibitor and a sensitizing PDGF-receptor blocker depends upon the stage of vascular maturation
    • R. Hlushchuk, O. Baum, and G. Gruber The synergistic action of a VEGF-receptor tyrosine-kinase inhibitor and a sensitizing PDGF-receptor blocker depends upon the stage of vascular maturation Microcirculation 14 8 2007 813 825
    • (2007) Microcirculation , vol.14 , Issue.8 , pp. 813-825
    • Hlushchuk, R.1    Baum, O.2    Gruber, G.3
  • 11
    • 38349156090 scopus 로고    scopus 로고
    • Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy
    • F. Gomi, M. Sawa, and H. Sakaguchi Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 1 2008 70 73
    • (2008) Br J Ophthalmol , vol.92 , Issue.1 , pp. 70-73
    • Gomi, F.1    Sawa, M.2    Sakaguchi, H.3
  • 12
    • 77949503824 scopus 로고    scopus 로고
    • Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: An interim 6-month report
    • G.T. Kokame, L. Yeung, and J.C. Lai Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: an interim 6-month report Br J Ophthalmol 94 3 2010 297 301
    • (2010) Br J Ophthalmol , vol.94 , Issue.3 , pp. 297-301
    • Kokame, G.T.1    Yeung, L.2    Lai, J.C.3
  • 13
    • 67349233537 scopus 로고    scopus 로고
    • Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy
    • M. Cho, I.A. Barbazetto, and K.B. Freund Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 148 1 2009 70 78
    • (2009) Am J Ophthalmol , vol.148 , Issue.1 , pp. 70-78
    • Cho, M.1    Barbazetto, I.A.2    Freund, K.B.3
  • 14
    • 3442875289 scopus 로고    scopus 로고
    • Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: One-year results of a prospective case series
    • W.M. Chan, D.S. Lam, and T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 8 2004 1576 1584
    • (2004) Ophthalmology , vol.111 , Issue.8 , pp. 1576-1584
    • Chan, W.M.1    Lam, D.S.2    Lai, T.Y.3
  • 15
    • 34748897185 scopus 로고    scopus 로고
    • Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization
    • C.M. Eandi, M.D. Ober, and K.B. Freund Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization Retina 27 7 2007 825 831
    • (2007) Retina , vol.27 , Issue.7 , pp. 825-831
    • Eandi, C.M.1    Ober, M.D.2    Freund, K.B.3
  • 16
    • 0025776268 scopus 로고
    • Guidelines for evaluation and treatment in the macular photocoagulation study: Macular Photocoagulation Study Group
    • Subfoveal neovascular lesions in age-related macular degeneration
    • Subfoveal neovascular lesions in age-related macular degeneration Guidelines for evaluation and treatment in the macular photocoagulation study Macular Photocoagulation Study Group Arch Ophthalmol 109 9 1991 1242 1257
    • (1991) Arch Ophthalmol , vol.109 , Issue.9 , pp. 1242-1257
  • 17
    • 0342632445 scopus 로고    scopus 로고
    • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trialsTAP report: Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group
    • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trialsTAP report Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group Arch Ophthalmol 117 10 1999 1329 1345
    • (1999) Arch Ophthalmol , vol.117 , Issue.10 , pp. 1329-1345
  • 18
    • 0031769927 scopus 로고    scopus 로고
    • American Academy of Ophthalmology
    • Indocyanine green angiography
    • Indocyanine green angiography American Academy of Ophthalmology Ophthalmology 105 8 1998 1564 1569
    • (1998) Ophthalmology , vol.105 , Issue.8 , pp. 1564-1569
  • 19
    • 0037224731 scopus 로고    scopus 로고
    • Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: An evidence-based update
    • P.E. Stanga, J.I. Lim, and P. Hamilton Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update Ophthalmology 110 1 2003 15 21
    • (2003) Ophthalmology , vol.110 , Issue.1 , pp. 15-21
    • Stanga, P.E.1    Lim, J.I.2    Hamilton, P.3
  • 20
    • 67651183724 scopus 로고    scopus 로고
    • To investigate the prevalence of polypoidal choroidal vasculopathy in presumed age-related peripapillary subretinal neovascular membranes
    • D.M. Squirrell, J.F. Bacon, and C.S. Brand To investigate the prevalence of polypoidal choroidal vasculopathy in presumed age-related peripapillary subretinal neovascular membranes Clin Experiment Ophthalmol 37 4 2009 368 372
    • (2009) Clin Experiment Ophthalmol , vol.37 , Issue.4 , pp. 368-372
    • Squirrell, D.M.1    Bacon, J.F.2    Brand, C.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.